Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Tegillidine and sufentanil for patient-controlled analgesia after knee replacement
ChiCTR2500109954Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tegillidine and sufentanil in postoperative pain (3 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Sum of pain intensity differences (SPID). Planned start Sep 2025; status: not yet recruiting.
02
Drugs
tegillidinesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500109954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109954.